Effects of antihistamines, acetylsalicylic acid and prednisone on cutaneous reactions to kallikrein and prostaglandin E1.
D000328:Adult; D001241:Aspirin / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology; D002908:Chronic Disease; D003533:Cyproheptadine / Q000494:pharmacology; D004342:Drug Hypersensitivity; D004485:Eczema; D005260:Female; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D007271:Injections, Intradermal; D007610:Kallikreins / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology; D012393:Rosacea; D012867:Skin / Q000187:drug effects*; D014581:Urticaria; D014647:Varicose Ulcer
D006634:Histamine H1 Antagonists; D011453:Prostaglandins; D011725:Pyridines; D003533:Cyproheptadine; D006632:Histamine; D007610:Kallikreins; D001241:Aspirin; D001920:Bradykinin; D011241:Prednisone